We consider a class of optimal control problems of stochastic delay differential equations (SDDE) that arise in connection with optimal advertising under uncertainty for the introduction of a new product to the market, generalizing classical work of Nerlove and Arrow [30]. In particular, we deal with controlled SDDE where the delay enters both the state and the control. Following ideas of Vinter and Kwong [34] (which however hold only in the deterministic case), we reformulate the problem as an infinite dimensional stochastic control problem to which we associate, through the dynamic programming principle, a second order Hamilton-Jacobi-Bellman equation. We show a verification theorem and we exhibit some simple cases where such equation admits an explicit smooth solution, allowing us to construct optimal feedback controls.
We consider an infinite horizon portfolio problem with borrowing constraints, in which an agent receives labor income which adjusts to financial market shocks in a path dependent way. This path-dependency is the novelty of the model, and leads to an infinite dimensional stochastic optimal control problem. We solve the problem completely, and find explicitly the optimal controls in feedback form. This is possible because we are able to find an explicit solution to the associated infinite dimensional Hamilton-Jacobi-Bellman (HJB) equation, even if state constraints are present. To the best of our knowledge, this is the first infinite dimensional generalization of Merton's optimal portfolio problem for which explicit solutions can be found. The explicit solution allows us to study the properties of optimal strategies and discuss their financial implications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.